

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 7.55599301 |
| 2 | actin-myosin filament sliding (GO:0033275) | 7.55599301 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 6.55548633 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.18701159 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.12807556 |
| 6 | actin-mediated cell contraction (GO:0070252) | 5.98693697 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.76374190 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.76374190 |
| 9 | skeletal muscle contraction (GO:0003009) | 5.54130765 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 5.49767224 |
| 11 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.35322111 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 5.32094831 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.32094831 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.08689749 |
| 15 | myofibril assembly (GO:0030239) | 5.04028751 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.77149835 |
| 17 | aldehyde catabolic process (GO:0046185) | 4.76885313 |
| 18 | striated muscle contraction (GO:0006941) | 4.69220179 |
| 19 | fatty acid elongation (GO:0030497) | 4.55038809 |
| 20 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.51713148 |
| 21 | sarcomere organization (GO:0045214) | 4.42884114 |
| 22 | cardiac myofibril assembly (GO:0055003) | 4.42239039 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.41728059 |
| 24 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 4.40857902 |
| 25 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 4.40857902 |
| 26 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.38603834 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.34447606 |
| 28 | cholesterol biosynthetic process (GO:0006695) | 4.28740904 |
| 29 | response to inactivity (GO:0014854) | 4.21502135 |
| 30 | regulation of sarcomere organization (GO:0060297) | 4.05331311 |
| 31 | cardiac muscle contraction (GO:0060048) | 4.02624641 |
| 32 | bile acid biosynthetic process (GO:0006699) | 3.99335033 |
| 33 | creatine metabolic process (GO:0006600) | 3.95113847 |
| 34 | carnitine transmembrane transport (GO:1902603) | 3.92931411 |
| 35 | actin filament-based movement (GO:0030048) | 3.84677011 |
| 36 | indole-containing compound catabolic process (GO:0042436) | 3.83361838 |
| 37 | indolalkylamine catabolic process (GO:0046218) | 3.83361838 |
| 38 | tryptophan catabolic process (GO:0006569) | 3.83361838 |
| 39 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.83319189 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81310898 |
| 41 | sterol biosynthetic process (GO:0016126) | 3.75775587 |
| 42 | carnitine transport (GO:0015879) | 3.72504464 |
| 43 | amino-acid betaine transport (GO:0015838) | 3.72504464 |
| 44 | cofactor catabolic process (GO:0051187) | 3.71628575 |
| 45 | heart contraction (GO:0060047) | 3.70690550 |
| 46 | heart process (GO:0003015) | 3.70690550 |
| 47 | alpha-linolenic acid metabolic process (GO:0036109) | 3.70534690 |
| 48 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.69290601 |
| 49 | tryptophan metabolic process (GO:0006568) | 3.65783170 |
| 50 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.64633553 |
| 51 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.64216756 |
| 52 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.63389997 |
| 53 | inositol phosphate dephosphorylation (GO:0046855) | 3.63389997 |
| 54 | inositol phosphate catabolic process (GO:0071545) | 3.60322866 |
| 55 | positive regulation of protein homodimerization activity (GO:0090073) | 3.59315398 |
| 56 | cardiac muscle hypertrophy (GO:0003300) | 3.57876896 |
| 57 | oxidative phosphorylation (GO:0006119) | 3.57116125 |
| 58 | regulation of cell communication by electrical coupling (GO:0010649) | 3.56426722 |
| 59 | ATP synthesis coupled proton transport (GO:0015986) | 3.56179790 |
| 60 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.56179790 |
| 61 | regulation of actin filament-based movement (GO:1903115) | 3.54315151 |
| 62 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.53093122 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.48478159 |
| 64 | aromatic amino acid family metabolic process (GO:0009072) | 3.48055318 |
| 65 | coenzyme catabolic process (GO:0009109) | 3.47803588 |
| 66 | striated muscle hypertrophy (GO:0014897) | 3.43878094 |
| 67 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.42889032 |
| 68 | protein carboxylation (GO:0018214) | 3.42889032 |
| 69 | nitrogen cycle metabolic process (GO:0071941) | 3.40966104 |
| 70 | signal peptide processing (GO:0006465) | 3.39406273 |
| 71 | tyrosine metabolic process (GO:0006570) | 3.39280421 |
| 72 | muscle contraction (GO:0006936) | 3.38812033 |
| 73 | kynurenine metabolic process (GO:0070189) | 3.37524187 |
| 74 | urea metabolic process (GO:0019627) | 3.37290166 |
| 75 | urea cycle (GO:0000050) | 3.37290166 |
| 76 | regulation of germinal center formation (GO:0002634) | 3.36897852 |
| 77 | neuronal action potential propagation (GO:0019227) | 3.36181918 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35588859 |
| 79 | bile acid metabolic process (GO:0008206) | 3.35057477 |
| 80 | interkinetic nuclear migration (GO:0022027) | 3.34684265 |
| 81 | myotube cell development (GO:0014904) | 3.33916048 |
| 82 | sulfur amino acid catabolic process (GO:0000098) | 3.33745673 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31997836 |
| 84 | heme transport (GO:0015886) | 3.31075072 |
| 85 | complement activation, alternative pathway (GO:0006957) | 3.30447219 |
| 86 | detection of calcium ion (GO:0005513) | 3.28171167 |
| 87 | cysteine metabolic process (GO:0006534) | 3.27762460 |
| 88 | regulation of striated muscle contraction (GO:0006942) | 3.26562013 |
| 89 | purinergic receptor signaling pathway (GO:0035587) | 3.26115756 |
| 90 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.25435513 |
| 91 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.25435513 |
| 92 | proteasome assembly (GO:0043248) | 3.23443438 |
| 93 | cartilage morphogenesis (GO:0060536) | 3.22225867 |
| 94 | very long-chain fatty acid metabolic process (GO:0000038) | 3.21978074 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 3.21827377 |
| 96 | muscle hypertrophy (GO:0014896) | 3.21194310 |
| 97 | skeletal muscle adaptation (GO:0043501) | 3.20934161 |
| 98 | muscle system process (GO:0003012) | 3.18066266 |
| 99 | ubiquinone biosynthetic process (GO:0006744) | 3.16045211 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.15827087 |
| 101 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.15572661 |
| 102 | relaxation of muscle (GO:0090075) | 3.15327701 |
| 103 | regulation of protein activation cascade (GO:2000257) | 3.15117978 |
| 104 | regulation of fibrinolysis (GO:0051917) | 3.11754341 |
| 105 | negative regulation of fibrinolysis (GO:0051918) | 3.11258554 |
| 106 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.11235136 |
| 107 | NADH metabolic process (GO:0006734) | 3.10393468 |
| 108 | carnitine shuttle (GO:0006853) | 3.09981771 |
| 109 | cellular ketone body metabolic process (GO:0046950) | 3.09459409 |
| 110 | negative regulation of heart rate (GO:0010459) | 3.07763850 |
| 111 | actomyosin structure organization (GO:0031032) | 3.05899127 |
| 112 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05668092 |
| 113 | protein-lipid complex remodeling (GO:0034368) | 3.05668092 |
| 114 | macromolecular complex remodeling (GO:0034367) | 3.05668092 |
| 115 | negative regulation of cation channel activity (GO:2001258) | 3.04236106 |
| 116 | amine catabolic process (GO:0009310) | 3.03405609 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 3.03405609 |
| 118 | positive regulation of cation channel activity (GO:2001259) | 3.02560836 |
| 119 | purine nucleotide salvage (GO:0032261) | 3.01767606 |
| 120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.01720192 |
| 121 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.00156898 |
| 122 | amino acid salvage (GO:0043102) | 2.98729784 |
| 123 | L-methionine salvage (GO:0071267) | 2.98729784 |
| 124 | L-methionine biosynthetic process (GO:0071265) | 2.98729784 |
| 125 | cholesterol efflux (GO:0033344) | 2.98522480 |
| 126 | arginine metabolic process (GO:0006525) | 2.98006979 |
| 127 | protein neddylation (GO:0045116) | 2.97563781 |
| 128 | glycogen catabolic process (GO:0005980) | 2.95365246 |
| 129 | regulation of triglyceride catabolic process (GO:0010896) | 2.94962471 |
| 130 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.94489435 |
| 131 | plasma lipoprotein particle clearance (GO:0034381) | 2.94474284 |
| 132 | imidazole-containing compound metabolic process (GO:0052803) | 2.94311710 |
| 133 | NAD biosynthetic process (GO:0009435) | 2.93125757 |
| 134 | L-serine metabolic process (GO:0006563) | 2.93123055 |
| 135 | regulation of complement activation (GO:0030449) | 2.92965110 |
| 136 | acyl-CoA metabolic process (GO:0006637) | 2.91061509 |
| 137 | thioester metabolic process (GO:0035383) | 2.91061509 |
| 138 | bile acid and bile salt transport (GO:0015721) | 2.90998213 |
| 139 | skeletal muscle fiber development (GO:0048741) | 2.89659034 |
| 140 | isoprenoid biosynthetic process (GO:0008299) | 2.89632254 |
| 141 | alkaloid metabolic process (GO:0009820) | 2.89166538 |
| 142 | regulation of ATP catabolic process (GO:1903289) | 2.88110683 |
| 143 | regulation of ATPase activity (GO:0043462) | 2.88110683 |
| 144 | ethanol oxidation (GO:0006069) | 2.88046462 |
| 145 | negative regulation of muscle contraction (GO:0045932) | 2.87912836 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.87114230 |
| 147 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.87114230 |
| 148 | opsonization (GO:0008228) | 2.86502591 |
| 149 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.85360907 |
| 150 | muscle fiber development (GO:0048747) | 2.85231709 |
| 151 | dopamine transport (GO:0015872) | 2.85088842 |
| 152 | glycine metabolic process (GO:0006544) | 2.84655114 |
| 153 | indolalkylamine metabolic process (GO:0006586) | 2.83682014 |
| 154 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.83528769 |
| 155 | response to muscle activity (GO:0014850) | 2.80554330 |
| 156 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.80473469 |
| 157 | blood coagulation, intrinsic pathway (GO:0007597) | 2.80005788 |
| 158 | steroid biosynthetic process (GO:0006694) | 2.79293265 |
| 159 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.78837590 |
| 160 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.78804143 |
| 161 | acetyl-CoA metabolic process (GO:0006084) | 2.78686312 |
| 162 | phospholipid efflux (GO:0033700) | 2.78352814 |
| 163 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.77966321 |
| 164 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.77540377 |
| 165 | regulation of platelet aggregation (GO:0090330) | 2.77167042 |
| 166 | serine family amino acid metabolic process (GO:0009069) | 2.77055032 |
| 167 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.76991400 |
| 168 | mitochondrial genome maintenance (GO:0000002) | 2.76414894 |
| 169 | axon ensheathment in central nervous system (GO:0032291) | 2.76290349 |
| 170 | central nervous system myelination (GO:0022010) | 2.76290349 |
| 171 | alpha-amino acid catabolic process (GO:1901606) | 2.76245065 |
| 172 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.76159110 |
| 173 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.76159110 |
| 174 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.75830095 |
| 175 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.74296902 |
| 176 | reverse cholesterol transport (GO:0043691) | 2.74147136 |
| 177 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.71860024 |
| 178 | glucan biosynthetic process (GO:0009250) | 2.71012872 |
| 179 | glycogen biosynthetic process (GO:0005978) | 2.71012872 |
| 180 | skeletal muscle tissue regeneration (GO:0043403) | 2.70674838 |
| 181 | quaternary ammonium group transport (GO:0015697) | 2.70041384 |
| 182 | striated muscle adaptation (GO:0014888) | 2.70017681 |
| 183 | 2-oxoglutarate metabolic process (GO:0006103) | 2.69562907 |
| 184 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.69258069 |
| 185 | amyloid precursor protein catabolic process (GO:0042987) | 2.69108408 |
| 186 | uronic acid metabolic process (GO:0006063) | 2.68805957 |
| 187 | glucuronate metabolic process (GO:0019585) | 2.68805957 |
| 188 | adenosine metabolic process (GO:0046085) | 2.68392233 |
| 189 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.67820774 |
| 190 | ketone body metabolic process (GO:1902224) | 2.67761609 |
| 191 | skeletal muscle tissue development (GO:0007519) | 2.67435688 |
| 192 | glucan catabolic process (GO:0009251) | 2.67006477 |
| 193 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.66930840 |
| 194 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.66930840 |
| 195 | regulation of sequestering of triglyceride (GO:0010889) | 2.66238126 |
| 196 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.66183064 |
| 197 | cellular polysaccharide catabolic process (GO:0044247) | 2.66179696 |
| 198 | ubiquinone metabolic process (GO:0006743) | 2.65024261 |
| 199 | regulation of membrane repolarization (GO:0060306) | 2.64831132 |
| 200 | negative regulation of calcium ion transport (GO:0051926) | 2.63651217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.04618110 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 5.03999195 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.27236866 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.19146914 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.00444841 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.88902590 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.85739695 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.67427562 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.54397925 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40664264 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.40469307 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.33568965 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.30028813 |
| 14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.26890490 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.21396296 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.19132633 |
| 17 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.00298655 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.87866932 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.80308371 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.73422019 |
| 21 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.68208966 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66433408 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.55070720 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.54756567 |
| 25 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.52513999 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42061764 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38889279 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.35483744 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.31640721 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.24009787 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20639998 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.20397135 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.20127772 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.16852784 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13032523 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10187382 |
| 37 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.09919319 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.03164842 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97681055 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95526160 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90438936 |
| 42 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.90381112 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.90050050 |
| 44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.86071164 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.85699150 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.85020171 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.79477238 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74083849 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73242716 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71400407 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.70998749 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67979765 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66250185 |
| 54 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64665280 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64223849 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.62099492 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.61457181 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57341604 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56364383 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54723498 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.52590864 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52373368 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50980233 |
| 64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49816555 |
| 65 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.48827288 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46090389 |
| 67 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44327463 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.42702169 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42251506 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41085241 |
| 71 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.35680387 |
| 72 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.35680387 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34287138 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32760048 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31189362 |
| 76 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.30455205 |
| 77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29693342 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29054654 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24847718 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24796981 |
| 81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24795438 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24795438 |
| 83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24670438 |
| 84 | AR_20517297_ChIP-Seq_VCAP_Human | 1.23895739 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23609241 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.22557509 |
| 87 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21657652 |
| 88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.21428498 |
| 89 | EWS_26573619_Chip-Seq_HEK293_Human | 1.21414210 |
| 90 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20503441 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20487892 |
| 92 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.20424453 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.19425799 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.18728473 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.17656396 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17552511 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17282471 |
| 98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16060810 |
| 99 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15710608 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14259465 |
| 101 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13482016 |
| 102 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.13118787 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12871274 |
| 104 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12863009 |
| 105 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.12292935 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12221573 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12045214 |
| 108 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11912759 |
| 109 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11727276 |
| 110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.11446715 |
| 111 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.10909442 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10214250 |
| 113 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08084949 |
| 114 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06967521 |
| 115 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06967521 |
| 116 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06519357 |
| 117 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04718687 |
| 118 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.04373794 |
| 119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04278897 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03993966 |
| 121 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03912249 |
| 122 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03348988 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02989687 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02017594 |
| 125 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01900955 |
| 126 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01586736 |
| 127 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01264926 |
| 128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01171281 |
| 129 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.00997962 |
| 130 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00994047 |
| 131 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99775331 |
| 132 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.97765978 |
| 133 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97668062 |
| 134 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.97281906 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97081239 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96306411 |
| 137 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96207180 |
| 138 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.95087125 |
| 139 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95081894 |
| 140 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94735541 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93277694 |
| 142 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93182361 |
| 143 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93144194 |
| 144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92627354 |
| 145 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.92422406 |
| 146 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91700134 |
| 147 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91526680 |
| 148 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91147094 |
| 149 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91138598 |
| 150 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90762048 |
| 151 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90394782 |
| 152 | NCOR_22424771_ChIP-Seq_293T_Human | 0.90352296 |
| 153 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.90071515 |
| 154 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90036164 |
| 155 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90035636 |
| 156 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89750643 |
| 157 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.89369897 |
| 158 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89343003 |
| 159 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89284718 |
| 160 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88066258 |
| 161 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87496992 |
| 162 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86602748 |
| 163 | * TTF2_22483619_ChIP-Seq_HELA_Human | 0.86492277 |
| 164 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86416823 |
| 165 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85742296 |
| 166 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85582708 |
| 167 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85050815 |
| 168 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84407075 |
| 169 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84286198 |
| 170 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84246898 |
| 171 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.81313845 |
| 172 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80876085 |
| 173 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80735309 |
| 174 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79445196 |
| 175 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.78357260 |
| 176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78141593 |
| 177 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77252913 |
| 178 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77170945 |
| 179 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.73817061 |
| 180 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.73784517 |
| 181 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73435230 |
| 182 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72537641 |
| 183 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72497626 |
| 184 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71413870 |
| 185 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71247594 |
| 186 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70760119 |
| 187 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.70608438 |
| 188 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.70579025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.79039971 |
| 2 | MP0005360_urolithiasis | 5.31724980 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.92925290 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 4.57034517 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.44996418 |
| 6 | MP0005365_abnormal_bile_salt | 4.41242434 |
| 7 | MP0003646_muscle_fatigue | 4.32058323 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.93350419 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.92496626 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.82403595 |
| 11 | MP0000751_myopathy | 3.41727925 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 3.32047204 |
| 13 | MP0004215_abnormal_myocardial_fiber | 3.07068879 |
| 14 | MP0009840_abnormal_foam_cell | 2.94560268 |
| 15 | MP0000749_muscle_degeneration | 2.85728208 |
| 16 | MP0002822_catalepsy | 2.74367166 |
| 17 | MP0003186_abnormal_redox_activity | 2.71069884 |
| 18 | MP0003195_calcinosis | 2.62067973 |
| 19 | MP0004130_abnormal_muscle_cell | 2.52009194 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.46789512 |
| 21 | MP0009379_abnormal_foot_pigmentation | 2.33634640 |
| 22 | MP0005670_abnormal_white_adipose | 2.31290815 |
| 23 | MP0009697_abnormal_copulation | 2.29531321 |
| 24 | MP0005083_abnormal_biliary_tract | 2.28060322 |
| 25 | MP0005451_abnormal_body_composition | 2.26788892 |
| 26 | MP0003724_increased_susceptibility_to | 2.22879428 |
| 27 | MP0005330_cardiomyopathy | 2.21361989 |
| 28 | MP0010329_abnormal_lipoprotein_level | 2.21061696 |
| 29 | MP0002332_abnormal_exercise_endurance | 2.20216092 |
| 30 | MP0005332_abnormal_amino_acid | 2.18029318 |
| 31 | MP0005620_abnormal_muscle_contractility | 2.13472178 |
| 32 | MP0001764_abnormal_homeostasis | 2.09116566 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 2.04845305 |
| 34 | MP0005369_muscle_phenotype | 2.02923264 |
| 35 | MP0000747_muscle_weakness | 2.01628617 |
| 36 | MP0009785_altered_susceptibility_to | 1.99869218 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.97305155 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.97188537 |
| 39 | MP0004087_abnormal_muscle_fiber | 1.95273554 |
| 40 | MP0003252_abnormal_bile_duct | 1.93465300 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.88718702 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.84616889 |
| 43 | MP0004484_altered_response_of | 1.82847594 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.81431561 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.73812641 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.67809718 |
| 47 | MP0002269_muscular_atrophy | 1.67229153 |
| 48 | MP0000920_abnormal_myelination | 1.65601106 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.65012965 |
| 50 | MP0005408_hypopigmentation | 1.61965649 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.59173723 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.59062832 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.57747085 |
| 54 | MP0000609_abnormal_liver_physiology | 1.57294720 |
| 55 | MP0003436_decreased_susceptibility_to | 1.55373403 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55347050 |
| 57 | MP0006082_CNS_inflammation | 1.53840727 |
| 58 | MP0005025_abnormal_response_to | 1.53320245 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.50817773 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.49958280 |
| 61 | MP0005385_cardiovascular_system_phenoty | 1.49739963 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.49739963 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 1.48975922 |
| 64 | MP0004085_abnormal_heartbeat | 1.44846620 |
| 65 | MP0000604_amyloidosis | 1.44667323 |
| 66 | MP0002419_abnormal_innate_immunity | 1.40225920 |
| 67 | MP0008469_abnormal_protein_level | 1.38330557 |
| 68 | MP0008872_abnormal_physiological_respon | 1.37066467 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 1.36897834 |
| 70 | MP0003137_abnormal_impulse_conducting | 1.36460490 |
| 71 | MP0005535_abnormal_body_temperature | 1.33649439 |
| 72 | MP0009764_decreased_sensitivity_to | 1.28623861 |
| 73 | MP0002971_abnormal_brown_adipose | 1.26933677 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.25761778 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.24578057 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.23046845 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.21923873 |
| 78 | MP0004510_myositis | 1.21024732 |
| 79 | MP0009763_increased_sensitivity_to | 1.20257861 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.20255564 |
| 81 | MP0003011_delayed_dark_adaptation | 1.20004199 |
| 82 | MP0002127_abnormal_cardiovascular_syste | 1.19768854 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.18874032 |
| 84 | MP0000230_abnormal_systemic_arterial | 1.18806509 |
| 85 | MP0001905_abnormal_dopamine_level | 1.17424732 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.17249319 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 1.16509005 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 1.15374181 |
| 89 | MP0003718_maternal_effect | 1.14660959 |
| 90 | MP0006138_congestive_heart_failure | 1.14197498 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.13482837 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 1.12972222 |
| 93 | MP0005645_abnormal_hypothalamus_physiol | 1.11855462 |
| 94 | MP0002132_abnormal_respiratory_system | 1.11749992 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 1.11503614 |
| 96 | MP0001545_abnormal_hematopoietic_system | 1.09731711 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.09731711 |
| 98 | MP0001529_abnormal_vocalization | 1.09218155 |
| 99 | MP0005058_abnormal_lysosome_morphology | 1.08167576 |
| 100 | MP0000685_abnormal_immune_system | 1.08040166 |
| 101 | MP0005671_abnormal_response_to | 1.05967101 |
| 102 | MP0003828_pulmonary_edema | 1.03909601 |
| 103 | MP0000598_abnormal_liver_morphology | 1.03381761 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 1.02958218 |
| 105 | MP0002876_abnormal_thyroid_physiology | 1.02204943 |
| 106 | MP0001501_abnormal_sleep_pattern | 1.01782182 |
| 107 | MP0008260_abnormal_autophagy | 1.00078139 |
| 108 | MP0003690_abnormal_glial_cell | 0.99582594 |
| 109 | MP0002723_abnormal_immune_serum | 0.99414738 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.98171662 |
| 111 | MP0001800_abnormal_humoral_immune | 0.95721809 |
| 112 | MP0000750_abnormal_muscle_regeneration | 0.95290873 |
| 113 | MP0001853_heart_inflammation | 0.94903164 |
| 114 | MP0009333_abnormal_splenocyte_physiolog | 0.94718222 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.94452608 |
| 116 | MP0003868_abnormal_feces_composition | 0.94402677 |
| 117 | MP0004885_abnormal_endolymph | 0.93567186 |
| 118 | MP0001845_abnormal_inflammatory_respons | 0.91409304 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.90122310 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.88198278 |
| 121 | MP0005164_abnormal_response_to | 0.88062400 |
| 122 | MP0005174_abnormal_tail_pigmentation | 0.85278316 |
| 123 | MP0006276_abnormal_autonomic_nervous | 0.84470398 |
| 124 | MP0009278_abnormal_bone_marrow | 0.84150844 |
| 125 | MP0005387_immune_system_phenotype | 0.83836462 |
| 126 | MP0001790_abnormal_immune_system | 0.83836462 |
| 127 | MP0008873_increased_physiological_sensi | 0.82846161 |
| 128 | MP0003329_amyloid_beta_deposits | 0.82633938 |
| 129 | MP0004134_abnormal_chest_morphology | 0.82387202 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.82172337 |
| 131 | MP0005266_abnormal_metabolism | 0.80126629 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.79028000 |
| 133 | MP0002420_abnormal_adaptive_immunity | 0.77781061 |
| 134 | MP0001819_abnormal_immune_cell | 0.77659313 |
| 135 | MP0004883_abnormal_blood_vessel | 0.77547930 |
| 136 | MP0002272_abnormal_nervous_system | 0.75766697 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.75342380 |
| 138 | MP0001851_eye_inflammation | 0.73368754 |
| 139 | MP0004233_abnormal_muscle_weight | 0.73147060 |
| 140 | MP0004147_increased_porphyrin_level | 0.72958409 |
| 141 | MP0002108_abnormal_muscle_morphology | 0.72042608 |
| 142 | MP0005410_abnormal_fertilization | 0.71468914 |
| 143 | MP0001188_hyperpigmentation | 0.70423453 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.68856104 |
| 145 | MP0001502_abnormal_circadian_rhythm | 0.68564763 |
| 146 | MP0009745_abnormal_behavioral_response | 0.68420752 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.67356530 |
| 148 | MP0004142_abnormal_muscle_tone | 0.67218274 |
| 149 | MP0001533_abnormal_skeleton_physiology | 0.66554009 |
| 150 | MP0001756_abnormal_urination | 0.66332805 |
| 151 | MP0001661_extended_life_span | 0.65391491 |
| 152 | MP0000372_irregular_coat_pigmentation | 0.65097510 |
| 153 | MP0004381_abnormal_hair_follicle | 0.64738389 |
| 154 | MP0005253_abnormal_eye_physiology | 0.63708544 |
| 155 | MP0001968_abnormal_touch/_nociception | 0.63376931 |
| 156 | MP0000716_abnormal_immune_system | 0.62456817 |
| 157 | MP0008057_abnormal_DNA_replication | 0.59673379 |
| 158 | MP0000343_altered_response_to | 0.59560850 |
| 159 | MP0009046_muscle_twitch | 0.59218213 |
| 160 | MP0005452_abnormal_adipose_tissue | 0.58681536 |
| 161 | MP0002405_respiratory_system_inflammati | 0.58494594 |
| 162 | MP0010386_abnormal_urinary_bladder | 0.57384819 |
| 163 | MP0002909_abnormal_adrenal_gland | 0.57256170 |
| 164 | MP0003303_peritoneal_inflammation | 0.57132589 |
| 165 | MP0001663_abnormal_digestive_system | 0.57013085 |
| 166 | MP0002429_abnormal_blood_cell | 0.56880074 |
| 167 | MP0005334_abnormal_fat_pad | 0.56681580 |
| 168 | MP0000465_gastrointestinal_hemorrhage | 0.56628096 |
| 169 | MP0001542_abnormal_bone_strength | 0.55955538 |
| 170 | MP0000249_abnormal_blood_vessel | 0.55726841 |
| 171 | MP0002160_abnormal_reproductive_system | 0.55696583 |
| 172 | MP0010155_abnormal_intestine_physiology | 0.54754223 |
| 173 | MP0005647_abnormal_sex_gland | 0.54600452 |
| 174 | MP0000689_abnormal_spleen_morphology | 0.54435788 |
| 175 | MP0001986_abnormal_taste_sensitivity | 0.53209647 |
| 176 | MP0001243_abnormal_dermal_layer | 0.52091556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.76094360 |
| 2 | Nemaline bodies (HP:0003798) | 7.59993839 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.41574774 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.34719428 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.56551229 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 5.36535697 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.35353763 |
| 8 | Distal arthrogryposis (HP:0005684) | 5.12739543 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.08204241 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 4.75158679 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.69580328 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.56329823 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.54875546 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.26449873 |
| 15 | Rimmed vacuoles (HP:0003805) | 4.18227970 |
| 16 | Bundle branch block (HP:0011710) | 4.12901668 |
| 17 | Myoglobinuria (HP:0002913) | 4.12553364 |
| 18 | Rhabdomyolysis (HP:0003201) | 4.07464360 |
| 19 | Sudden death (HP:0001699) | 4.01302689 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 3.98028857 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.93832440 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.88308785 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.87900214 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.87900214 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 3.83034194 |
| 26 | Frequent falls (HP:0002359) | 3.74481133 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 3.70566276 |
| 28 | Xanthomatosis (HP:0000991) | 3.68665079 |
| 29 | Areflexia of lower limbs (HP:0002522) | 3.60520774 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 3.58020576 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 3.55271202 |
| 32 | Myopathic facies (HP:0002058) | 3.42472476 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 3.38981852 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.37077018 |
| 35 | Neck muscle weakness (HP:0000467) | 3.33671929 |
| 36 | Round ear (HP:0100830) | 3.27658675 |
| 37 | Hepatic necrosis (HP:0002605) | 3.25544490 |
| 38 | Acute encephalopathy (HP:0006846) | 3.23419869 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 3.19512088 |
| 40 | Cerebral edema (HP:0002181) | 3.19452839 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 3.19384680 |
| 42 | Asymmetric septal hypertrophy (HP:0001670) | 3.16138458 |
| 43 | Mitochondrial inheritance (HP:0001427) | 3.15997182 |
| 44 | Joint hemorrhage (HP:0005261) | 3.15207225 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.09831298 |
| 46 | Fat malabsorption (HP:0002630) | 3.07905574 |
| 47 | Hepatocellular necrosis (HP:0001404) | 3.07384372 |
| 48 | Subaortic stenosis (HP:0001682) | 3.02852354 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.02852354 |
| 50 | Metaphyseal dysplasia (HP:0100255) | 3.02319451 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 3.00328303 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93160086 |
| 53 | Complement deficiency (HP:0004431) | 2.91578499 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91537124 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.90761728 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.90407443 |
| 57 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.89851629 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87408086 |
| 59 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.84464001 |
| 60 | Increased CSF lactate (HP:0002490) | 2.83789437 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.81866850 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.81685203 |
| 63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.79906787 |
| 64 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.78219672 |
| 65 | Difficulty running (HP:0009046) | 2.76246162 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.75917149 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74564637 |
| 68 | Glycosuria (HP:0003076) | 2.74091231 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.74091231 |
| 70 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74074304 |
| 71 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73594692 |
| 72 | Steatorrhea (HP:0002570) | 2.73296452 |
| 73 | Hypolipoproteinemia (HP:0010981) | 2.72298191 |
| 74 | Parakeratosis (HP:0001036) | 2.71429905 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.71310192 |
| 76 | Hypoglycemic coma (HP:0001325) | 2.69095499 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65717282 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.63042753 |
| 79 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61235582 |
| 80 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58940323 |
| 81 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58940323 |
| 82 | Exertional dyspnea (HP:0002875) | 2.58263412 |
| 83 | Myotonia (HP:0002486) | 2.56432427 |
| 84 | Hyperammonemia (HP:0001987) | 2.56251664 |
| 85 | Increased muscle lipid content (HP:0009058) | 2.55578022 |
| 86 | Facial diplegia (HP:0001349) | 2.52332512 |
| 87 | Progressive macrocephaly (HP:0004481) | 2.50240030 |
| 88 | Heart block (HP:0012722) | 2.49517202 |
| 89 | Muscle stiffness (HP:0003552) | 2.48618935 |
| 90 | Epidermoid cyst (HP:0200040) | 2.48516491 |
| 91 | Hyperbilirubinemia (HP:0002904) | 2.47312334 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 2.46955308 |
| 93 | Lethargy (HP:0001254) | 2.45783745 |
| 94 | Renal cortical cysts (HP:0000803) | 2.42261155 |
| 95 | B lymphocytopenia (HP:0010976) | 2.40452908 |
| 96 | Increased serum lactate (HP:0002151) | 2.39478849 |
| 97 | Absent phalangeal crease (HP:0006109) | 2.38322942 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.38244326 |
| 99 | Lipoatrophy (HP:0100578) | 2.37880390 |
| 100 | Ulnar deviation of the wrist (HP:0003049) | 2.37267254 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36754523 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.36754523 |
| 103 | Abnormality of lateral ventricle (HP:0030047) | 2.34580021 |
| 104 | Abnormality of the intrinsic pathway (HP:0010989) | 2.34193655 |
| 105 | Dilated cardiomyopathy (HP:0001644) | 2.33557307 |
| 106 | Leukodystrophy (HP:0002415) | 2.32524145 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 2.31619877 |
| 108 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.27313652 |
| 109 | Systemic lupus erythematosus (HP:0002725) | 2.26952019 |
| 110 | Ventricular tachycardia (HP:0004756) | 2.26447279 |
| 111 | Lactic acidosis (HP:0003128) | 2.26349038 |
| 112 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21180559 |
| 113 | Abnormality of the renal cortex (HP:0011035) | 2.20174724 |
| 114 | Calcaneovalgus deformity (HP:0001848) | 2.18041936 |
| 115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16473345 |
| 116 | Spastic paraparesis (HP:0002313) | 2.16128997 |
| 117 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.15860435 |
| 118 | Abnormal atrioventricular conduction (HP:0005150) | 2.15433579 |
| 119 | Abnormality of B cell number (HP:0010975) | 2.15210049 |
| 120 | Hypercholesterolemia (HP:0003124) | 2.15065853 |
| 121 | Recurrent bacterial skin infections (HP:0005406) | 2.14778859 |
| 122 | Abnormality of serum amino acid levels (HP:0003112) | 2.13784518 |
| 123 | Abnormality of complement system (HP:0005339) | 2.12836705 |
| 124 | Abnormality of renal resorption (HP:0011038) | 2.11051461 |
| 125 | Opisthotonus (HP:0002179) | 2.10103775 |
| 126 | Ketosis (HP:0001946) | 2.10022166 |
| 127 | Hyperglycinemia (HP:0002154) | 2.09922442 |
| 128 | Hepatosplenomegaly (HP:0001433) | 2.09092069 |
| 129 | Delayed CNS myelination (HP:0002188) | 2.08931494 |
| 130 | Syncope (HP:0001279) | 2.08785692 |
| 131 | Febrile seizures (HP:0002373) | 2.08473100 |
| 132 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08305109 |
| 133 | Abnormality of alanine metabolism (HP:0010916) | 2.08305109 |
| 134 | Hyperalaninemia (HP:0003348) | 2.08305109 |
| 135 | Exercise intolerance (HP:0003546) | 2.06461947 |
| 136 | Abnormal finger flexion creases (HP:0006143) | 2.06460751 |
| 137 | Distal lower limb muscle weakness (HP:0009053) | 2.05925650 |
| 138 | Hyperphosphaturia (HP:0003109) | 2.05330091 |
| 139 | Generalized muscle weakness (HP:0003324) | 2.03772408 |
| 140 | Atrial fibrillation (HP:0005110) | 2.02547940 |
| 141 | Irritability (HP:0000737) | 2.02450778 |
| 142 | Purpura (HP:0000979) | 2.02260039 |
| 143 | Abnormality of the foot musculature (HP:0001436) | 2.02251334 |
| 144 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.01093815 |
| 145 | Type I transferrin isoform profile (HP:0003642) | 2.00549191 |
| 146 | Ventricular arrhythmia (HP:0004308) | 2.00047349 |
| 147 | Abnormal number of erythroid precursors (HP:0012131) | 1.99896098 |
| 148 | Malignant hyperthermia (HP:0002047) | 1.99453606 |
| 149 | Left ventricular hypertrophy (HP:0001712) | 1.97250280 |
| 150 | Abnormality of glycine metabolism (HP:0010895) | 1.96409974 |
| 151 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96409974 |
| 152 | Bulbar palsy (HP:0001283) | 1.95838414 |
| 153 | Metabolic acidosis (HP:0001942) | 1.94770077 |
| 154 | Progressive muscle weakness (HP:0003323) | 1.94541443 |
| 155 | Respiratory failure (HP:0002878) | 1.94437172 |
| 156 | Medial flaring of the eyebrow (HP:0010747) | 1.94309992 |
| 157 | Deformed tarsal bones (HP:0008119) | 1.90654774 |
| 158 | Prolonged neonatal jaundice (HP:0006579) | 1.89784411 |
| 159 | Glomerulonephritis (HP:0000099) | 1.89759166 |
| 160 | Abnormal pupillary function (HP:0007686) | 1.89335136 |
| 161 | Primary atrial arrhythmia (HP:0001692) | 1.88577606 |
| 162 | Long clavicles (HP:0000890) | 1.88464228 |
| 163 | Vomiting (HP:0002013) | 1.88397815 |
| 164 | CNS demyelination (HP:0007305) | 1.88146248 |
| 165 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87287046 |
| 166 | Recurrent abscess formation (HP:0002722) | 1.86331150 |
| 167 | Abnormality of the prostate (HP:0008775) | 1.85792250 |
| 168 | Macrocytic anemia (HP:0001972) | 1.85631219 |
| 169 | Nausea (HP:0002018) | 1.84187066 |
| 170 | Ragged-red muscle fibers (HP:0003200) | 1.83726076 |
| 171 | Abnormality of macrophages (HP:0004311) | 1.83624577 |
| 172 | Fatigue (HP:0012378) | 1.83592315 |
| 173 | Cerebral hemorrhage (HP:0001342) | 1.82291941 |
| 174 | Neurofibrillary tangles (HP:0002185) | 1.82125730 |
| 175 | Brushfield spots (HP:0001088) | 1.81451127 |
| 176 | Foot dorsiflexor weakness (HP:0009027) | 1.81245001 |
| 177 | Supraventricular tachycardia (HP:0004755) | 1.79945093 |
| 178 | Abnormality of midbrain morphology (HP:0002418) | 1.79608017 |
| 179 | Molar tooth sign on MRI (HP:0002419) | 1.79608017 |
| 180 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75808198 |
| 181 | Hypoplasia of the thymus (HP:0000778) | 1.74461068 |
| 182 | Thyroiditis (HP:0100646) | 1.73605151 |
| 183 | Gowers sign (HP:0003391) | 1.72645365 |
| 184 | Supraventricular arrhythmia (HP:0005115) | 1.72541373 |
| 185 | Abnormal EKG (HP:0003115) | 1.72150564 |
| 186 | Nephronophthisis (HP:0000090) | 1.71414162 |
| 187 | Weak cry (HP:0001612) | 1.68176719 |
| 188 | Papilledema (HP:0001085) | 1.67434326 |
| 189 | Impaired proprioception (HP:0010831) | 1.66872068 |
| 190 | Steppage gait (HP:0003376) | 1.66655081 |
| 191 | Epistaxis (HP:0000421) | 1.66488780 |
| 192 | Agammaglobulinemia (HP:0004432) | 1.66461315 |
| 193 | Paralysis (HP:0003470) | 1.65268042 |
| 194 | Visual hallucinations (HP:0002367) | 1.63565823 |
| 195 | Petechiae (HP:0000967) | 1.62437737 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.21404549 |
| 2 | PHKG1 | 3.90068893 |
| 3 | PHKG2 | 3.90068893 |
| 4 | STK16 | 3.48842123 |
| 5 | PBK | 3.34195242 |
| 6 | PINK1 | 3.16396697 |
| 7 | TTN | 2.65960885 |
| 8 | TESK2 | 2.57033047 |
| 9 | LIMK1 | 2.56588908 |
| 10 | BCKDK | 2.55911656 |
| 11 | NME2 | 2.52268981 |
| 12 | PIM2 | 2.48967060 |
| 13 | ARAF | 2.40620561 |
| 14 | BMPR1B | 2.32545617 |
| 15 | MAPKAPK3 | 2.32346788 |
| 16 | FRK | 2.29828805 |
| 17 | EIF2AK3 | 2.28597242 |
| 18 | DYRK2 | 2.20487951 |
| 19 | MAP4K2 | 2.07434150 |
| 20 | BCR | 2.06372585 |
| 21 | EIF2AK1 | 2.03414813 |
| 22 | BUB1 | 2.01464215 |
| 23 | MST4 | 2.01224033 |
| 24 | MAPK12 | 2.00870609 |
| 25 | STK39 | 1.91506293 |
| 26 | RIPK4 | 1.89258893 |
| 27 | MAP3K14 | 1.73479353 |
| 28 | TAOK3 | 1.64155096 |
| 29 | IRAK4 | 1.62990551 |
| 30 | CSNK1G3 | 1.61994785 |
| 31 | BLK | 1.53121083 |
| 32 | ABL2 | 1.44500520 |
| 33 | TYK2 | 1.44316301 |
| 34 | EPHB1 | 1.44095539 |
| 35 | TRPM7 | 1.44027623 |
| 36 | PTK2B | 1.42398985 |
| 37 | VRK1 | 1.41905684 |
| 38 | TBK1 | 1.41306653 |
| 39 | MAPK7 | 1.36490914 |
| 40 | KDR | 1.36323842 |
| 41 | SCYL2 | 1.35033439 |
| 42 | FGFR4 | 1.33198140 |
| 43 | KIT | 1.32269039 |
| 44 | MAP4K1 | 1.30385811 |
| 45 | MYLK | 1.29812365 |
| 46 | ADRBK2 | 1.28714958 |
| 47 | MAPK13 | 1.23616824 |
| 48 | FES | 1.21760015 |
| 49 | TEC | 1.21233752 |
| 50 | OXSR1 | 1.20354737 |
| 51 | TNK2 | 1.17199602 |
| 52 | CSNK1A1L | 1.16927572 |
| 53 | NUAK1 | 1.16679402 |
| 54 | WEE1 | 1.16074226 |
| 55 | ERBB4 | 1.13775785 |
| 56 | DYRK3 | 1.13641870 |
| 57 | GRK5 | 1.10314374 |
| 58 | MAP3K12 | 1.10146038 |
| 59 | DAPK2 | 1.08037420 |
| 60 | CSNK1G1 | 1.06752256 |
| 61 | GRK1 | 1.06221540 |
| 62 | INSRR | 1.02356162 |
| 63 | IRAK3 | 1.01641086 |
| 64 | MUSK | 1.01155537 |
| 65 | TIE1 | 0.98408578 |
| 66 | SIK3 | 0.97836685 |
| 67 | IKBKB | 0.97518529 |
| 68 | TXK | 0.94928623 |
| 69 | MAP2K3 | 0.93427768 |
| 70 | MAPKAPK5 | 0.92099853 |
| 71 | ERBB3 | 0.91680901 |
| 72 | MAPK4 | 0.91459298 |
| 73 | EIF2AK2 | 0.91104892 |
| 74 | CSF1R | 0.88605049 |
| 75 | IKBKE | 0.86606432 |
| 76 | TESK1 | 0.84514437 |
| 77 | MAP2K6 | 0.82633938 |
| 78 | JAK3 | 0.81959378 |
| 79 | ZAP70 | 0.81873615 |
| 80 | MAP3K7 | 0.80180491 |
| 81 | PIK3CG | 0.79979247 |
| 82 | TGFBR1 | 0.78718109 |
| 83 | CLK1 | 0.78299545 |
| 84 | UHMK1 | 0.77919951 |
| 85 | PRKAA2 | 0.77275230 |
| 86 | PKN1 | 0.76153037 |
| 87 | ACVR1B | 0.73995343 |
| 88 | TLK1 | 0.73338321 |
| 89 | PRKG1 | 0.73043266 |
| 90 | CSNK1G2 | 0.71702731 |
| 91 | RPS6KA5 | 0.71423601 |
| 92 | BRAF | 0.68964618 |
| 93 | SYK | 0.66692257 |
| 94 | BTK | 0.66626294 |
| 95 | GRK6 | 0.66457331 |
| 96 | SRPK1 | 0.65983140 |
| 97 | EPHA3 | 0.65532362 |
| 98 | CAMK2D | 0.65485413 |
| 99 | MET | 0.64087970 |
| 100 | BMPR2 | 0.63934995 |
| 101 | CCNB1 | 0.63890647 |
| 102 | LYN | 0.62016829 |
| 103 | IRAK1 | 0.61265095 |
| 104 | ZAK | 0.61253641 |
| 105 | ITK | 0.60775507 |
| 106 | IRAK2 | 0.60765645 |
| 107 | CAMK2A | 0.60591179 |
| 108 | NLK | 0.59780694 |
| 109 | RPS6KB2 | 0.58357121 |
| 110 | LCK | 0.57800011 |
| 111 | YES1 | 0.55935521 |
| 112 | GRK7 | 0.55472529 |
| 113 | PRKACA | 0.54334012 |
| 114 | MAP3K11 | 0.53414549 |
| 115 | FLT3 | 0.53295946 |
| 116 | NME1 | 0.52680740 |
| 117 | MAP3K5 | 0.52418445 |
| 118 | ILK | 0.51314607 |
| 119 | MAP2K2 | 0.50396874 |
| 120 | EEF2K | 0.49760946 |
| 121 | DAPK3 | 0.49690573 |
| 122 | CSNK2A1 | 0.49189426 |
| 123 | MKNK1 | 0.48925062 |
| 124 | PAK1 | 0.48834887 |
| 125 | DYRK1B | 0.48800731 |
| 126 | PRKCD | 0.47893312 |
| 127 | CAMK2G | 0.47031469 |
| 128 | PRKCE | 0.46947149 |
| 129 | CAMK2B | 0.46877440 |
| 130 | CAMK1 | 0.46270555 |
| 131 | PRKCQ | 0.45619293 |
| 132 | MAPK15 | 0.45453192 |
| 133 | PRKAA1 | 0.44684120 |
| 134 | ERN1 | 0.44123021 |
| 135 | MARK1 | 0.43515481 |
| 136 | TGFBR2 | 0.42928280 |
| 137 | PRKACB | 0.42695250 |
| 138 | PLK2 | 0.42640203 |
| 139 | PASK | 0.41762228 |
| 140 | HCK | 0.41286374 |
| 141 | CDK19 | 0.40865937 |
| 142 | ADRBK1 | 0.40795669 |
| 143 | TNIK | 0.39840881 |
| 144 | MATK | 0.39627192 |
| 145 | PIK3CA | 0.39331463 |
| 146 | MARK3 | 0.39214438 |
| 147 | CDK3 | 0.38391247 |
| 148 | CSNK2A2 | 0.37854075 |
| 149 | PIM1 | 0.37810916 |
| 150 | NTRK3 | 0.37555566 |
| 151 | PRKD1 | 0.37141921 |
| 152 | AURKA | 0.36987699 |
| 153 | PRKACG | 0.33946174 |
| 154 | MAPK11 | 0.32035592 |
| 155 | MAP2K4 | 0.29761796 |
| 156 | STK3 | 0.28994549 |
| 157 | PDK1 | 0.27800327 |
| 158 | PRKCA | 0.27794207 |
| 159 | MAP2K1 | 0.27630471 |
| 160 | WNK3 | 0.26899863 |
| 161 | CDC42BPA | 0.26606778 |
| 162 | ROCK1 | 0.25918289 |
| 163 | MAPK3 | 0.24662063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.58876576 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.41339757 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06046591 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.04494155 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.75012429 |
| 6 | Circadian rhythm_Homo sapiens_hsa04710 | 2.64535399 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.60848452 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55624034 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.54351364 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.48567662 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.40789527 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.21767626 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17402376 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15369134 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09851485 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.94680323 |
| 17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92445149 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92331344 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.92238913 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89092429 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.88839275 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85567964 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.84855904 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83721085 |
| 25 | Platelet activation_Homo sapiens_hsa04611 | 1.83605914 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.76849489 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.72033977 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69384228 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.68425044 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68008959 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.67857577 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67393108 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.65977668 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65566512 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63596186 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59769768 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.59721236 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58040405 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.56478120 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56266674 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54110484 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.52302623 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52023566 |
| 44 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47930154 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42311605 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39995079 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36222087 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.34188126 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34027699 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.33476685 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29185569 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.27000870 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.26890259 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26662715 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23552689 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21538873 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 1.21290094 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20085238 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19596416 |
| 60 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17489855 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16223029 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15093894 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14910145 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12846487 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12548368 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12198862 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10481341 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09943941 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08826546 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.07015961 |
| 71 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05500309 |
| 72 | DNA replication_Homo sapiens_hsa03030 | 1.03990482 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03268297 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01682635 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.99825184 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99430115 |
| 77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99390797 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99233045 |
| 79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98235617 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97814666 |
| 81 | Phototransduction_Homo sapiens_hsa04744 | 0.97020075 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95604687 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94598566 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93782851 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92003931 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.90241681 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.90224810 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89268639 |
| 89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.88918659 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88630830 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86398877 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84200780 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.83230990 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82894393 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81126366 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79707751 |
| 97 | Mismatch repair_Homo sapiens_hsa03430 | 0.79394567 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79347485 |
| 99 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78793295 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78198949 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78057685 |
| 102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75549905 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73331542 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70183944 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68959899 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.67354625 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.66187868 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66096788 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64834116 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62774868 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62721886 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61107508 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60764315 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56888961 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55663412 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55599621 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54178527 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51026393 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51001191 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48435124 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46424027 |
| 122 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45982422 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.45126036 |
| 124 | Legionellosis_Homo sapiens_hsa05134 | 0.44508324 |
| 125 | Base excision repair_Homo sapiens_hsa03410 | 0.43848300 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.42793425 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41898769 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41737547 |
| 129 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41700045 |
| 130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41518315 |
| 131 | Morphine addiction_Homo sapiens_hsa05032 | 0.40918558 |
| 132 | Phagosome_Homo sapiens_hsa04145 | 0.40767525 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40433949 |
| 134 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39080056 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36938454 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36927836 |
| 137 | Homologous recombination_Homo sapiens_hsa03440 | 0.36236187 |
| 138 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.36204263 |
| 139 | Allograft rejection_Homo sapiens_hsa05330 | 0.36168028 |
| 140 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35410259 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.34151007 |
| 142 | Purine metabolism_Homo sapiens_hsa00230 | 0.32618065 |
| 143 | Bile secretion_Homo sapiens_hsa04976 | 0.32474754 |
| 144 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28048167 |
| 145 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26999960 |
| 146 | Lysosome_Homo sapiens_hsa04142 | 0.26984021 |
| 147 | Spliceosome_Homo sapiens_hsa03040 | 0.24714752 |
| 148 | Asthma_Homo sapiens_hsa05310 | 0.24573005 |
| 149 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23818843 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.23807386 |

